Breast Cancer
Researchers describe findings in breast cancer studies
Published in OBGYN and Reproduction Week, May 23rd, 2005
Study 1: 5F 203 (2-(4-Amino-3-methylphenyl)-5-fluoro-benzothiazole) induces NF-kappa B activity in drug-sensitive human breast cancer MCF-7 cells.
According to recent research from the United States, "5F 203 potently inhibits MCF-7 breast cancer cell growth in part by activating the aryl hydrocarbon receptor (AhR) signaling pathway. Ligands for the AhR (i.e. dioxin) have also been shown to modulate the NF-kappaB signaling cascade, affecting physiological processes such as cellular immunity, inflammation, proliferation and survival."
"The objective...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of OBGYN and Reproduction Week
More Articles from OBGYN and Reproduction Week
- Cervical Cancer
Failure to screen, Pap test failure most common reasons for diagnosis - Obstetrics
Depression is common during pregnancy but often goes undetected - Obstetrics
TENS preferred over metamizole for afterpains - Reproductive Medicine
Human eggs can develop from ovarian surface cells in vitro - Uterine Cancer
Clomiphene citrate to induce ovulation may increase cancer risk - Addiction Medicine
Coping skills may aid women being physically abused by alcoholic partner - More from this issue of OBGYN and Reproduction Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
